Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The role of the opioid system in controlling pain, reward and addiction is well established, but its role in regulating other emotional responses is poorly documented in pharmacology. The mu-, delta- and kappa- opioid receptors (encoded by Oprm, Oprd1 and Oprk1, respectively) mediate the biological activity of opioids. We have generated Oprd1-deficient mice and compared the behavioural responses of mice lacking Oprd1, Oprm (ref. 6) and Oprk1 (ref. 7) in several models of anxiety and depression. Our data show no detectable phenotype in Oprk1-/- mutants, suggesting that kappa-receptors do not have a role in this aspect of opioid function; opposing phenotypes in Oprm-/- and Oprd1-/- mutants which contrasts with the classical notion of similar activities of mu- and delta-receptors; and consistent anxiogenic- and depressive-like responses in Oprd1-/- mice, indicating that delta-receptor activity contributes to improvement of mood states. We conclude that the Oprd1-encoded receptor, which has been proposed to be a promising target for the clinical management of pain, should also be considered in the treatment of drug addiction and other mood-related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, agonism of the delta-opioid receptor, the primary receptor target of enkephalin, promotes antidepressant outcomes (80), while delta receptor knockout promotes depressive-like behavior (81).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [81]
Citations
Cites
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 3,320
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Self-citationOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationTimpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J. M. H. M., Stalla, G. K., Blanquet, V., Steckler, T., Holsboer, F., & Wurst, W. (1998) · Nature Genetics · doi:10.1038/520 · Cited by 919
Lufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationDecreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J.-M., Lüscher, B., & Mohler, H. (1999) · Nature Neuroscience · doi:10.1038/12207 · Cited by 550
Cited by
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551
Reward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
Self-citationThe neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779
Neurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 777
The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Sheng, J., Liu, S., Wang, Y., Cui, R., & Zhang, X. (2017) · Neural Plasticity · doi:10.1155/2017/9724371 · Cited by 775
Waldhoer, M., Bartlett, S. E., & Whistler, J. L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073940 · Cited by 740
Anatomical Profiling of G Protein-Coupled Receptor Expression
Regard, J. B., Sato, I. T., & Coughlin, S. R. (2008) · Cell · doi:10.1016/j.cell.2008.08.040 · Cited by 693
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620
Self-citationCryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Opioid receptors: Distinct roles in mood disorders
Lutz, P.-E., & Kieffer, B. L. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.002 · Cited by 542
Self-citationInvolvement of CB1 cannabinoid receptors in emotional behaviour
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0946-5 · Cited by 507
Self-citationHuman N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Planagumà, J., Leypoldt, F., Mannara, F., Gutiérrez-Cuesta, J., Martín-García, E., Aguilar, E., Titulaer, M. J., Petit-Pedrol, M., Jain, A., Balice-Gordon, R., et al. (2015) · Brain · doi:10.1093/brain/awu310 · Cited by 489
Self-citationDynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y.-Q., Contet, C., Mennicken, F., O'Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 462
Self-citationDeficit in Attachment Behavior in Mice Lacking the µ-Opioid Receptor Gene
Moles, A., Kieffer, B. L., & D'Amato, F. R. (2004) · Science · doi:10.1126/science.1095943 · Cited by 449
Self-citationMcLaughlin, J. P., Marton-Popovici, M., & Chavkin, C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05674.2003 · Cited by 430
Role of endogenous opioid system in the regulation of the stress response
Drolet, G., Dumont, É. C., Gosselin, I., Kinkead, R., Laforest, S., & Trottier, J.-F. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00161-0 · Cited by 421
Regulation of Human Affective Responses by Anterior Cingulate and Limbic µ-Opioid Neurotransmission
Zubieta, J.-K., Ketter, T. A., Bueller, J. A., Xu, Y., Kilbourn, M. R., Young, E. A., & Koeppe, R. A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1145 · Cited by 377
The delta opioid receptor: an evolving target for the treatment of brain disorders
Pradhan, A. A., Befort, K., Nozaki, C., Gavériaux-Ruff, C., & Kieffer, B. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.008 · Cited by 365
Self-citationOpioid receptors: drivers to addiction?
Darcq, E., & Kieffer, B. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 352
Self-citationDysregulation of Endogenous Opioid Emotion Regulation Circuitry in Major Depression in Women
Kennedy, S. E., Koeppe, R. A., Young, E. A., & Zubieta, J.-K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1199 · Cited by 338
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
The mesoaccumbens dopamine in coping with stress
Cabib, S., & Puglisi-Allegra, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.012 · Cited by 329
Current Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine
Valjent, E., Mitchell, J. M., Besson, M., Caboche, J., & Maldonado, R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704479 · Cited by 321
Self-citationCastro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 290
Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala
Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300858 · Cited by 289
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Schwarzer, C. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.006 · Cited by 289
The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor
Samuels, B. A., Nautiyal, K. M., Kruegel, A. C., Levinstein, M. R., Magalong, V. M., Gassaway, M. M., Grinnell, S. G., Han, J., Ansonoff, M. A., Pintar, J. E., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.60 · Cited by 274
Neural Systems Underlying Opiate Addiction
De Vries, T. J., & Shippenberg, T. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03321.2002 · Cited by 270
Burke, N. N., Finn, D. P., McGuire, B. E., & Roche, M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23802 · Cited by 268
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors
Ghozland, S., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263
Self-citationThe Endomorphin System and Its Evolving Neurophysiological Role
Fichna, J., Janecka, A., Costentin, J., & Do Rego, J.-C. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.1.3 · Cited by 250
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
Scherrer, G., Tryoen-Tóth, P., Filliol, D., Matifas, A., Laustriat, D., Cao, Y. Q., Basbaum, A. I., Dierich, A., Vonesh, J.-L., Gavériaux-Ruff, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603359103 · Cited by 243
Self-citationPharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models
Stewart, A., Wu, N., Cachat, J., Hart, P., Gaikwad, S., Wong, K., Utterback, E., Gilder, T., Kyzar, E., Newman, A., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.035 · Cited by 240
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
Increased Abundance of Opioid Receptor Heteromers After Chronic Morphine Administration
Gupta, A., Mulder, J., Gomes, I., Rozenfeld, R., Bushlin, I., Ong, E., Lim, M., Maillet, E., Junek, M., Cahill, C. M., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000807 · Cited by 226
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol
Berrendero, F., & Maldonado, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 222
Self-citationShirayama, Y., & Chaki, S. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520773 · Cited by 225
From monoamines to genomic targets: a paradigm shift for drug discovery in depression
Wong, M.-L., & Licinio, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1303 · Cited by 225
Pharmacokinetic-Pharmacodynamic Crisis in the Elderly
ELDesoky, E. S. (2007) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000183719.84390.4d · Cited by 219
Imaging of opioid receptors in the central nervous system
Henriksen, G., & Willoch, F. (2008) · Brain · doi:10.1093/brain/awm255 · Cited by 214
Genetic susceptibility to heroin addiction: a candidate gene association study
Levran, O., Londono, D., O’Hara, K., Nielsen, D. A., Peles, E., Rotrosen, J., Casadonte, P., Linzy, S., Randesi, M., Ott, J., et al. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00410.x · Cited by 208
Withdrawal from chronic amphetamine induces Depressive-Like behavioral effects in rodents
Cryan, J. F., Hoyer, D., & Markou, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01730-4 · Cited by 199
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Peciña, M., Karp, J. F., Mathew, S., Todtenkopf, M. S., Ehrich, E. W., & Zubieta, J.-K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0117-2 · Cited by 190
Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways
Wisner, A., Dufour, E., Messaoudi, M., Nejdi, A., Marcel, A., Ungeheuer, M.-N., & Rougeot, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605865103 · Cited by 186
Opioid receptors: From binding sites to visible molecules in vivo
Kieffer, B. L., & Evans, C. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.033 · Cited by 180
Self-citationCahill, C. M., Holdridge, S. V., & Morinville, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.11.003 · Cited by 184
In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists
Pradhan, A. A. A., Becker, J. A. J., Scherrer, G., Tryoen-Toth, P., Filliol, D., Matifas, A., Massotte, D., Gavériaux-Ruff, C., & Kieffer, B. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005425 · Cited by 177
Self-citationMechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways
Taylor, C., Fricker, A. D., Devi, L. A., & Gomes, I. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.007 · Cited by 186
Saitoh, A., Kimura, Y., Suzuki, T., Kawai, K., Nagase, H., & Kamei, J. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fpj04014x · Cited by 180
Endogenous opioid peptides in the descending pain modulatory circuit
Bagley, E. E., & Ingram, S. L. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108131 · Cited by 181
Opioid system and human emotions
Nummenmaa, L., & Tuominen, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13812 · Cited by 178
Opioid receptor genes inactivated in mice: the highlights
Gavériaux-Ruff, C., & Kieffer, B. L. (2002) · Neuropeptides · doi:10.1054/npep.2002.0900 · Cited by 178
Self-citationNonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats
Broom, D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00413-4 · Cited by 175
Delta opioid receptors in brain function and diseases
Chu Sin Chung, P., & Kieffer, B. L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.003 · Cited by 159
Self-citationIncreased Ethanol Self‐Administration in δ‐Opioid Receptor Knockout Mice
Roberts, A. J., Gold, L. H., Polis, I., McDonald, J. S., Filliol, D., Kieffer, B. L., & Koob, G. F. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02344.x · Cited by 166
Self-citationGaveriaux-Ruff, C., Nozaki, C., Nadal, X., Hever, X. C., Weibel, R., Matifas, A., Reiss, D., Filliol, D., Nassar, M. A., Wood, J. N., et al. (2011) · Pain · doi:10.1016/j.pain.2010.12.031 · Cited by 161
Self-citationPhilippe, D., Dubuquoy, L., Groux, H., Brun, V., Chuoï-Mariot, M. T. V., Gaveriaux-Ruff, C., Colombel, J.-F., Kieffer, B. L., & Desreumaux, P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16750 · Cited by 171
Self-citationThe dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 179
Hebb, A. L. O., Poulin, J.-F., Roach, S. P., Zacharko, R. M., & Drolet, G. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.008 · Cited by 170
Serafini, G., Adavastro, G., Canepa, G., De Berardis, D., Valchera, A., Pompili, M., Nasrallah, H., & Amore, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082410 · Cited by 162
Zhang, H., Kranzler, H. R., Yang, B.-Z., Luo, X., & Gelernter, J. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002035 · Cited by 160
Charbogne, P., Kieffer, B. L., & Befort, K. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.028 · Cited by 162
Self-citationKappa-opioid ligands in the study and treatment of mood disorders
Carlezon, W. A., Béguin, C., Knoll, A. T., & Cohen, B. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.008 · Cited by 167
Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits
Wang, D., Tawfik, V. L., Corder, G. F., Low, S. A., François, A., Basbaum, A. I., & Scherrer, G. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.002 · Cited by 169
Faouzi, A., Varga, B. R., & Majumdar, S. (2020) · Molecules · doi:10.3390/molecules25184257 · Cited by 157
Ligand‐directed signalling within the opioid receptor family
Pradhan, A. A. A., Smith, M. L., Kieffer, B. L., & Evans, C. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02075.x · Cited by 156
Self-citationSchuckit, M. A., Smith, T. L., & Kalmijn, J. A. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000141637.01925.f6 · Cited by 168
Female preproenkephalin-knockout mice display altered emotional responses
Ragnauth, A. K., Schuller, A. G., Morgan, M. A., Chan, J. S. W., Ogawa, S., Pintar, J. E., Bodnar, R. J., & Pfaff, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1958 · Cited by 154
Ribeiro, S. C. M., Kennedy, S. E., Smith, Y. R., Stohler, C. S., & Zubieta, J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.011 · Cited by 166
Challenges for opioid receptor nomenclature: IUPHAR Review 9
Cox, B. M., Christie, M. J., Devi, L. A., Toll, L., & Traynor, J. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12612 · Cited by 151
Ligand-Directed Trafficking of the δ-Opioid ReceptorIn Vivo: Two Paths Toward Analgesic Tolerance
Pradhan, A. A. A., Walwyn, W. M., Nozaki, C., Filliol, D., Erbs, E., Matifas, A., Evans, C. J., & Kieffer, B. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3748-10.2010 · Cited by 149
Self-citationSamaco, R. C., Mandel‐Brehm, C., McGraw, C. M., Shaw, C. A., McGill, B. E., & Zoghbi, H. Y. (2012) · Nature Genetics · doi:10.1038/ng.1066 · Cited by 157
Delta opioid receptor ligands modulate anxiety‐like behaviors in the rat
Perrine, S. A., Hoshaw, B. A., & Unterwald, E. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706686 · Cited by 143
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort, K. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 151
Self-citationNitsche, J. F., Schuller, A. G., King, M. A., Zengh, M., Pasternak, G. W., & Pintar, J. E. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10906.2002 · Cited by 144
Merrer, J. L., Plaza‐Zabala, A., Boca, C. D., Matifas, A., Maldonado, R. J., & Kieffer, B. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.10.021 · Cited by 134
Self-citationBerrocoso, E., Sánchez‐Blázquez, P., Garzón, J., & Micó, J. A. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168100 · Cited by 131
Autistic-Like Syndrome in Mu Opioid Receptor Null Mice is Relieved by Facilitated mGluR4 Activity
Becker, J. A. J., Clesse, D., Spiegelhalter, C., Schwab, Y., Merrer, J. L., & Kieffer, B. L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.59 · Cited by 130
Self-citationThe Antidepressant -like Effects of Delta-Opioid Receptor Agonists
Jutkiewicz, E. M. (2006) · Molecular Interventions · doi:10.1124/mi.6.3.7 · Cited by 127
Engel, S. R., Creson, T. K., Hao, Y., Shen, Y., Maeng, S., Nekrasova, T., Landreth, G. E., Manji, H. K., & Chen, G. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002135 · Cited by 135
Relative contribution of peripheral versus central opioid receptors to antinociception
Łabuz, D., Mousa, S. A., Schäfer, M., Stein, C., & Machelska, H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.049 · Cited by 126
From Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 144
Hebb, A. L. O., Zacharko, R. M., Gauthier, M. S., Trudel, F., Laforest, S., & Drolet, G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03704.x · Cited by 122
Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches
Gavériaux‐Ruff, C., & Kieffer, B. L. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32834a1f2c · Cited by 121
Self-citationPerrine, S. A., Sheikh, I. S., Nwaneshiudu, C. A., Schroeder, J. A., & Unterwald, E. M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.10.007 · Cited by 130
Gianoulakis, C., Dai, X., & Brown, T. G. (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000056614.96137.b8 · Cited by 121
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors
Falcon, E., Browne, C. A., Leon, R. M., Fleites, V. C., Sweeney, R., Kirby, L. G., & Lucki, I. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.38 · Cited by 118
Altered central μ-opioid receptor binding after psychological trauma
Liberzon, I., Taylor, S. F., Phan, K. L., Britton, J. C., Fig, L. M., Bueller, J. A., Koeppe, R. A., & Zubieta, J.-K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.021 · Cited by 118
Neurobiology of Kratom and its main alkaloid mitragynine
Suhaimi, F. W., Yusoff, N. H. M., Hassan, R., Mansor, S. M., Navaratnam, V., Müller, C. P., & Hassan, Z. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.015 · Cited by 123
Neuropathic pain is enhanced in δ‐opioid receptor knockout mice
Nadal, X., Baños, J.-E., Kieffer, B. L., & Maldonado, R. J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04569.x · Cited by 118
Self-citationInflammatory pain is enhanced in delta opioid receptor‐knockout mice
Gavériaux‐Ruff, C., Karchewski, L. A., Hever, X. C., Matifas, A., & Kieffer, B. L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06223.x · Cited by 117
Self-citationColasanti, A., Rabiner, E. A., Lingford-Hughes, A. R., & Nutt, D. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367726 · Cited by 116
Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs
Nathan, P. J., O’Neill, B. V., Napolitano, A., & Bullmore, E. T. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00172.x · Cited by 126
Pradhan, A. A. A., Smith, M. L., Zyuzin, J., & Charles, A. C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12591 · Cited by 116
Metadata
- Authors
- Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universitat Pompeu Fabra (ES)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Corresponding author
- Kieffer, Brigitte L.
- ORCID
- Venue
- Nature Genetics
- Published
- 2000-06
- Volume
- 25
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1505495051
- Cited by
- 672
- References
- 31
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 15 · 2023: 19 · 2022: 18 · 2021: 16 · 2020: 24 · 2019: 29 · 2018: 28 · 2017: 30 · 2016: 41 · 2015: 24 · 2014: 39 · 2013: 35 · 2012: 33
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- delta opioid receptor, mu-opioid receptor, kappa opioid receptor, OprM, anxiety-like behavior, depression-like behavior, emotion regulation, mood disorders, drug addiction, pain
- MeSH terms
- Animals, Anxiety, Binding Sites, Darkness, Depression, Electroshock, Female, Light, Male, Motor Activity, Naloxone, Naltrexone, Narcotic Antagonists, Phenotype, Sex Characteristics, Swimming, Pain Threshold, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.